Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 46.86%2.82B | 3.05%4.48B | 1.16%1.92B | 33.57%4.35B | 34.67%1.9B | -23.52%3.25B | -42.14%1.41B | 40.26%4.26B | 106.18%2.43B | 0.73%3.03B |
| Operating income | 46.86%2.82B | 3.05%4.48B | 1.16%1.92B | 33.57%4.35B | 34.67%1.9B | -23.52%3.25B | -42.14%1.41B | 40.26%4.26B | 106.18%2.43B | 0.73%3.03B |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Depreciation and amortization | -2.82%-481.1M | -8.12%-1.01B | -4.93%-467.9M | -17.73%-930.2M | -27.00%-445.9M | 12.02%-790.1M | 22.68%-351.1M | 3.21%-898M | -11.60%-454.1M | 4.31%-927.8M |
| Impairment and provision | ---- | ---53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -12.10%-1.28B | 15.74%-2.43B | 9.62%-1.14B | -67.83%-2.88B | -66.65%-1.26B | -12.37%-1.72B | 19.09%-756.3M | 7.52%-1.53B | -17.33%-934.8M | -6.70%-1.65B |
| Operating profit | 240.34%1.06B | 86.20%990M | 63.82%311.1M | -28.66%531.7M | -36.83%189.9M | -59.22%745.3M | -71.22%300.6M | 304.38%1.83B | 4,583.26%1.04B | 32.17%451.9M |
| Financing income | -49.26%6.9M | -8.64%22.2M | 216.28%13.6M | 62.00%24.3M | 26.47%4.3M | 177.78%15M | 325.00%3.4M | 184.21%5.4M | -33.33%800K | -83.04%1.9M |
| Financing cost | 19.38%-146.4M | -6.66%-390.8M | 1.63%-181.6M | -22.21%-366.4M | -31.39%-184.6M | 8.88%-299.8M | 17.35%-140.5M | 18.04%-329M | 23.29%-170M | 23.27%-401.4M |
| Earning before tax | 542.42%919.3M | 227.74%621.4M | 1,390.63%143.1M | -58.83%189.6M | -94.13%9.6M | -69.38%460.5M | -81.32%163.5M | 2,769.85%1.5B | 459.21%875.4M | 130.82%52.4M |
| Tax | -455.03%-353M | -278.37%-255.4M | -84.35%-63.6M | 68.89%-67.5M | 53.19%-34.5M | 62.80%-217M | 74.71%-73.7M | -1,146.37%-583.3M | -577.70%-291.4M | -84.98%-46.8M |
| After-tax profit from continuing operations | 612.33%566.3M | 199.75%366M | 419.28%79.5M | -49.86%122.1M | -127.73%-24.9M | -73.55%243.5M | -84.62%89.8M | 16,337.50%920.5M | 419.65%584M | 102.87%5.6M |
| Earning after tax | 612.33%566.3M | 199.75%366M | 419.28%79.5M | -49.86%122.1M | -127.73%-24.9M | -73.55%243.5M | -84.62%89.8M | 16,337.50%920.5M | 419.65%584M | 102.87%5.6M |
| Minority profit | 287.50%226.3M | 80.46%204.1M | 72.27%58.4M | 59.07%113.1M | 229.13%33.9M | -71.94%71.1M | -94.40%10.3M | 260.46%253.4M | 844.53%183.9M | 100.28%70.3M |
| Profit attributable to shareholders | 1,511.37%340M | 1,698.89%161.9M | 135.88%21.1M | -94.78%9M | -173.96%-58.8M | -74.16%172.4M | -80.13%79.5M | 1,131.07%667.1M | 353.23%400.1M | 71.92%-64.7M |
| Basic earnings per share | 1,117.39%0.028 | 1,430.00%0.0153 | 135.94%0.0023 | -95.00%0.001 | -169.57%-0.0064 | -74.84%0.02 | -81.26%0.0092 | 1,093.75%0.0795 | 350.51%0.0491 | 72.03%-0.008 |
| Diluted earnings per share | 1,117.39%0.028 | 1,420.00%0.0152 | 135.94%0.0023 | -94.95%0.001 | -169.57%-0.0064 | -74.81%0.0198 | -81.07%0.0092 | 1,082.50%0.0786 | 347.96%0.0486 | 72.03%-0.008 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.